Hypoxia-Inducible Factor Signaling Provides Protection in Clostridium difficile-Induced Intestinal Injury
Simon A. Hirota(University of Calgary), Paul L. Beck(University of Calgary), Yan Li(Beijing Tongren Hospital), Thomas Louie(Alberta Health Services), Justin A. MacDonald(University of Calgary), Daniel A. Muruve(University of Calgary), Kyla Fines(University of Calgary), Sean P. Colgan(Brigham and Women's Hospital), Manigandan Lejeune(Cornell University), William G. Willmore(Carleton University), Kris Chadee(University of Calgary), Jeffrey Ng(University of Calgary), Daniel C. Chung(Icahn School of Medicine at Mount Sinai), Glen D. Armstrong(University of Calgary), Eikichi Ihara(University of Calgary), Josh Lee(University of Calgary), Danya Traboulsi(University of Calgary), Shaun Medlicott(University of Calgary), Melanie Scully(University of Colorado Anschutz Medical Campus)
Cited by 102
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Fidaxomicin versus Vancomycin for <i>Clostridium difficile</i> Infection
|New England Journal of Medicine|2011|1.6k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k